{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T14:26:28Z","timestamp":1767968788672,"version":"3.49.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T00:00:00Z","timestamp":1620345600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA033572"],"award-info":[{"award-number":["P30CA033572"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 CA229510-01"],"award-info":[{"award-number":["R01 CA229510-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","award":["2325-19"],"award-info":[{"award-number":["2325-19"]}],"id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Support Care Cancer"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1007\/s00520-021-06241-6","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T19:04:20Z","timestamp":1620414260000},"page":"6669-6679","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["The impact of gender, age, race\/ethnicity, and stage on quality of life in a spectrum of cutaneous lymphomas"],"prefix":"10.1007","volume":"29","author":[{"given":"Xochiquetzal U.","family":"Martinez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arnab","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tracey","family":"Stiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joycelynne","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Loscalzo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Estella","family":"Barrios","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Farah R.","family":"Abdulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasmine","family":"Zain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven T.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christiane","family":"Querfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,5,7]]},"reference":[{"key":"6241_CR1","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","volume":"133","author":"R Willemze","year":"2019","unstructured":"Willemze R, Cerroni L, Kempf W, Berti E, Facchetti F, Swerdlow SH, et al. The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas. Blood. 2019.","journal-title":"Blood"},{"issue":"10","key":"6241_CR2","doi-asserted-by":"publisher","first-page":"2504","DOI":"10.1002\/cncr.22252","volume":"107","author":"MF Demierre","year":"2006","unstructured":"Demierre MF, Gan S, Jones J, Miller DR (2006) Significant impact of cutaneous T-cell lymphoma on patients\u2019 quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey. Cancer 107(10):2504\u20132511","journal-title":"Cancer"},{"issue":"3","key":"6241_CR3","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1001\/archderm.141.3.325","volume":"141","author":"MF Demierre","year":"2005","unstructured":"Demierre MF, Tien A, Miller D (2005) Health-related quality-of-life assessment in patients with cutaneous T-cell lymphoma. Arch Dermatol 141(3):325\u2013330","journal-title":"Arch Dermatol"},{"issue":"11","key":"6241_CR4","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/ijd.14132","volume":"57","author":"HM Holahan","year":"2018","unstructured":"Holahan HM, Farah RS, Fitz S, Mott SL, Ferguson NN, McKillip J et al (2018) Health-related quality of life in patients with cutaneous T-cell lymphoma? Int J Dermatol 57(11):1314\u20131319","journal-title":"Int J Dermatol"},{"issue":"11","key":"6241_CR5","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1111\/ijd.14132","volume":"57","author":"HM Holahan","year":"2018","unstructured":"Molloy K, Jonak C, Woei AJF, Guenova E, Busschots AM, Bervoets A, et al. Characteristics associated with significantly worse quality of life in mycosis fungoides\/Sezary syndrome from the Prospective Cutaneous Lymphoma International Prognostic Index (PROCLIPI) study. The British journal of dermatology. 2019.","journal-title":"Int J Dermatol"},{"issue":"4","key":"6241_CR6","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1111\/j.1365-2133.2008.08992.x","volume":"160","author":"F Sampogna","year":"2009","unstructured":"Sampogna F, Frontani M, Baliva G, Lombardo GA, Alvetreti G, Di Pietro C et al (2009) Quality of life and psychological distress in patients with cutaneous lymphoma. Br J Dermatol 160(4):815\u2013822","journal-title":"Br J Dermatol"},{"issue":"1","key":"6241_CR7","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1016\/j.jpainsymman.2012.01.012","volume":"45","author":"A Wright","year":"2013","unstructured":"Wright A, Wijeratne A, Hung T, Gao W, Whittaker S, Morris S et al (2013) Prevalence and severity of pruritus and quality of life in patients with cutaneous T-cell lymphoma. J Pain Symptom Manage 45(1):114\u2013119","journal-title":"J Pain Symptom Manage"},{"issue":"7","key":"6241_CR8","doi-asserted-by":"publisher","first-page":"640","DOI":"10.2340\/00015555-3171","volume":"99","author":"C Jonak","year":"2019","unstructured":"Jonak C, Porkert S, Oerlemans S, Papadavid E, Molloy K, Lehner-Baumgartner E et al (2019) Health-related quality of life in cutaneous lymphomas: past, present and future. Acta Derm Venereol 99(7):640\u2013646","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"6241_CR9","first-page":"26","volume":"63","author":"AM Posada-Cano","year":"2019","unstructured":"Posada-Cano AM, Valencia-Ocampo OJ, Vel\u00e1squez-Lopera MM (2019) Assessment of the quality of life in patients with cutaneous lymphoma. Dermatol Rev Mex 63(1):26\u201339","journal-title":"Dermatol Rev Mex"},{"issue":"2","key":"6241_CR10","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1177\/120347540100500202","volume":"5","author":"MM Chren","year":"2001","unstructured":"Chren MM, Lasek RJ, Sahay AP, Sands LP (2001) Measurement properties of Skindex-16: a brief quality-of-life measure for patients with skin diseases. J Cutan Med Surg 5(2):105\u2013110","journal-title":"J Cutan Med Surg"},{"issue":"11","key":"6241_CR11","doi-asserted-by":"publisher","first-page":"1433","DOI":"10.1001\/archderm.1997.03890470111018","volume":"133","author":"MM Chren","year":"1997","unstructured":"Chren MM, Lasek RJ, Flocke SA, Zyzanski SJ (1997) Improved discriminative and evaluative capability of a refined version of Skindex, a quality-of-life instrument for patients with skin diseases. Arch Dermatol 133(11):1433\u20131440","journal-title":"Arch Dermatol"},{"issue":"6","key":"6241_CR12","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1182\/blood-2007-03-055749","volume":"110","author":"E Olsen","year":"2007","unstructured":"Olsen E, Vonderheid E, Pimpinelli N, Willemze R, Kim Y, Knobler R et al (2007) Revisions to the staging and classification of mycosis fungoides and Sezary syndrome: a proposal of the International Society for Cutaneous Lymphomas (ISCL) and the cutaneous lymphoma task force of the European Organization of Research and Treatment of Cancer (EORTC). Blood 110(6):1713\u20131722","journal-title":"Blood"},{"issue":"3","key":"6241_CR13","doi-asserted-by":"publisher","first-page":"398","DOI":"10.2307\/2095231","volume":"48","author":"DR Johnson","year":"1983","unstructured":"Johnson DR, Creech JC (1983) Ordinal measures in multiple indicator models: a simulation study of categorization error. Am Sociol Rev 48(3):398\u2013407","journal-title":"Am Sociol Rev"},{"issue":"5","key":"6241_CR14","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1007\/s10459-010-9222-y","volume":"15","author":"G Norman","year":"2010","unstructured":"Norman G (2010) Likert scales, levels of measurement and the \u201claws\u201d of statistics. Adv Health Sci Educ Theory Pract 15(5):625\u2013632","journal-title":"Adv Health Sci Educ Theory Pract"},{"issue":"4","key":"6241_CR15","doi-asserted-by":"publisher","first-page":"541","DOI":"10.4300\/JGME-5-4-18","volume":"5","author":"GM Sullivan","year":"2013","unstructured":"Sullivan GM, Artino AR Jr (2013) Analyzing and interpreting data from likert-type scales. J Grad Med Educ 5(4):541\u2013542","journal-title":"J Grad Med Educ"},{"issue":"4","key":"6241_CR16","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1037\/h0078865","volume":"34","author":"BD Zumbo","year":"1993","unstructured":"Zumbo BD, Zimmerman DW (1993) Is the selection of statistical methods governed by level of measurement? Can Psychol 34(4):390\u2013400","journal-title":"Can Psychol"},{"issue":"21","key":"6241_CR17","doi-asserted-by":"publisher","first-page":"5064","DOI":"10.1182\/blood-2008-10-184168","volume":"113","author":"PT Bradford","year":"2009","unstructured":"Bradford PT, Devesa SS, Anderson WF, Toro JR (2009) Cutaneous lymphoma incidence patterns in the United States: a population-based study of 3884 cases. Blood 113(21):5064\u20135073","journal-title":"Blood"},{"issue":"2","key":"6241_CR18","doi-asserted-by":"publisher","first-page":"430","DOI":"10.1016\/j.jaad.2019.08.073","volume":"83","author":"S Geller","year":"2020","unstructured":"Geller S, Lebowitz E, Pulitzer MP, Horwitz SM, Moskowitz AJ, Dusza S et al (2020) Outcomes and prognostic factors in African American and black patients with mycosis fungoides\/Sezary syndrome: retrospective analysis of 157 patients from a referral cancer center. J Am Acad Dermatol 83(2):430\u2013439","journal-title":"J Am Acad Dermatol"},{"issue":"4","key":"6241_CR19","doi-asserted-by":"publisher","first-page":"752","DOI":"10.3109\/10428194.2012.729831","volume":"54","author":"MH Imam","year":"2013","unstructured":"Imam MH, Shenoy PJ, Flowers CR, Phillips A, Lechowicz MJ (2013) Incidence and survival patterns of cutaneous T-cell lymphomas in the United States. Leuk Lymphoma 54(4):752\u2013759","journal-title":"Leuk Lymphoma"},{"issue":"5","key":"6241_CR20","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.clml.2013.12.018","volume":"14","author":"SK Nath","year":"2014","unstructured":"Nath SK, Yu JB, Wilson LD (2014) Poorer prognosis of African-American patients with mycosis fungoides: an analysis of the SEER dataset, 1988 to 2008. Clin Lymphoma Myeloma Leuk 14(5):419\u2013423","journal-title":"Clin Lymphoma Myeloma Leuk"},{"issue":"3","key":"6241_CR21","doi-asserted-by":"publisher","first-page":"497-+","DOI":"10.1016\/j.jaad.2017.04.1137","volume":"77","author":"C Su","year":"2017","unstructured":"Su C, Nguyen KA, Bai HX, Cao Y, Tao YG, Xiao R, et al. Racial disparity in mycosis fungoides: An analysis of 4495 cases from the US National Cancer Database. J Am Acad Dermatol. 2017;77(3):497-+.","journal-title":"J Am Acad Dermatol"},{"issue":"11","key":"6241_CR22","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1097\/01.COT.0000484648.06098.2f","volume":"38","author":"E Susman","year":"2016","unstructured":"Susman E (2016) S\u00e9zary syndrome discriminates among ethnicities. Oncology Times 38(11):20","journal-title":"Oncology Times"},{"issue":"1","key":"6241_CR23","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1002\/(SICI)1097-0142(19990101)85:1<208::AID-CNCR28>3.0.CO;2-2","volume":"85","author":"MA Weinstock","year":"1999","unstructured":"Weinstock MA, Reynes JF (1999) The changing survival of patients with mycosis fungoides: a population-based assessment of trends in the United States. Cancer 85(1):208\u2013212","journal-title":"Cancer"},{"issue":"1","key":"6241_CR24","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10549-016-3963-0","volume":"160","author":"CA Samuel","year":"2016","unstructured":"Samuel CA, Pinheiro LC, Reeder-Hayes KE, Walker JS, Corbie-Smith G, Fashaw SA et al (2016) To be young, Black, and living with breast cancer: a systematic review of health-related quality of life in young Black breast cancer survivors. Breast Cancer Res Treat 160(1):1\u201315","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"6241_CR25","first-page":"302","volume":"22","author":"J Ye","year":"2012","unstructured":"Ye J, Shim R, Garrett SL, Daniels E (2012) Health-related quality of life in elderly black and white patients with cancer: results from Medicare managed care population. Ethn Dis 22(3):302\u2013307","journal-title":"Ethn Dis"},{"issue":"6","key":"6241_CR26","doi-asserted-by":"publisher","first-page":"2281","DOI":"10.1016\/S0022-5347(05)65551-6","volume":"166","author":"DP Lubeck","year":"2001","unstructured":"Lubeck DP, Kim H, Grossfeld G, Ray P, Penson DF, Flanders SC et al (2001) Health related quality of life differences between black and white men with prostate cancer: data from the cancer of the prostate strategic urologic research endeavor. J Urol 166(6):2281\u20132285","journal-title":"J Urol"},{"issue":"2","key":"6241_CR27","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1002\/(SICI)1097-0142(19990115)85:2<418::AID-CNCR20>3.0.CO;2-9","volume":"85","author":"K Ashing-Giwa","year":"1999","unstructured":"Ashing-Giwa K, Ganz PA, Petersen L (1999) Quality of life of African-American and white long term breast carcinoma survivors. Cancer 85(2):418\u2013426","journal-title":"Cancer"},{"issue":"6","key":"6241_CR28","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.juro.2007.01.138","volume":"177","author":"SD Ramsey","year":"2007","unstructured":"Ramsey SD, Zeliadt SB, Hall IJ, Ekwueme DU, Penson DF (2007) On the importance of race, socioeconomic status and comorbidity when evaluating quality of life in men with prostate cancer. J Urol 177(6):1992\u20131999","journal-title":"J Urol"},{"issue":"27","key":"6241_CR29","doi-asserted-by":"publisher","first-page":"6576","DOI":"10.1200\/JCO.2005.06.102","volume":"23","author":"JZ Ayanian","year":"2005","unstructured":"Ayanian JZ, Zaslavsky AM, Guadagnoli E, Fuchs CS, Yost KJ, Creech CM et al (2005) Patients\u2019 perceptions of quality of care for colorectal cancer by race, ethnicity, and language. J Clin Oncol Off J Am Soc Clin Oncol 23(27):6576\u20136586","journal-title":"J Clin Oncol Off J Am Soc Clin Oncol"},{"issue":"8","key":"6241_CR30","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1002\/cncr.29808","volume":"122","author":"HP Kale","year":"2016","unstructured":"Kale HP, Carroll NV (2016) Self-reported financial burden of cancer care and its effect on physical and mental health-related quality of life among US cancer survivors. Cancer 122(8):283\u2013289","journal-title":"Cancer"},{"issue":"2","key":"6241_CR31","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1353\/hpu.2005.0037","volume":"16","author":"TL Krupski","year":"2005","unstructured":"Krupski TL, Fink A, Kwan L, Maliski S, Connor SE, Clerkin B et al (2005) Health-related quality-of-life in low-income, uninsured men with prostate cancer. J Health Care Poor Underserved 16(2):375\u2013390","journal-title":"J Health Care Poor Underserved"},{"issue":"2","key":"6241_CR32","doi-asserted-by":"publisher","first-page":"240","DOI":"10.2340\/00015555-2819","volume":"98","author":"S Porkert","year":"2018","unstructured":"Porkert S, Lehner-Baumgartner E, Valencak J, Knobler R, Riedl E, Jonak C (2018) Patients\u2019 illness perception as a tool to improve individual disease management in primary cutaneous lymphomas. Acta Derm Venereol 98(2):240\u2013245","journal-title":"Acta Derm Venereol"}],"container-title":["Supportive Care in Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00520-021-06241-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00520-021-06241-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,25]],"date-time":"2021-09-25T08:11:54Z","timestamp":1632557514000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00520-021-06241-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,5,7]]},"references-count":32,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["6241"],"URL":"https:\/\/doi.org\/10.1007\/s00520-021-06241-6","relation":{},"ISSN":["0941-4355","1433-7339"],"issn-type":[{"value":"0941-4355","type":"print"},{"value":"1433-7339","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,5,7]]},"assertion":[{"value":"5 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 April 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 May 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was exempt from IRB review under 45CFR46.104 (d), and consent was not required. The study was approved for a Waiver of HIPAA Authorization (45CFR164.512(i)(2)(ii)).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"X.U.M., A.C., T.S., E.B.: none. J.P.: statistical consultant to Gilead Sciences; statistics instructor for ASTCT. M.L.: consultant to AstraZeneca. F.R.A.: consultant to Mallinckrodt; speaker\u2019s bureau for Mallinckrodt; receives grant\/research support from Johnson & Johnson, Elorac, Trillium, Stemline, MiRagen, Bioniz, and Mallinckrodt. J.Z.: consultant to Kyowa Kirin, Seattle Genetics, and Mundi Pharma. S.T.R.: speaker\u2019s bureau for Celgene, Global Education Group and Paradigm Medical Communications, LLC, and Abbvie; consultant to Novartis Pharmaceuticals Corporation, Pepromene Bio, Inc, Exicure, and Apobiologix\/Apotex Inc.; education advisory board to Seattle Genetics, NeoGenomics, and Aileron Therapeutics, Inc; has stock options with Pepromene Bio, Inc, and Exicure. C.Q<u>.<\/u>: Consultant to MiRagen, Helsinn\/Actelion, Medvir, Stemline Therapeutics, Trillium, Bioniz, and Kyowa Kirin; contracted clinical investigator\/researcher to MiRagen, Helsinn\/Actelion, Bioniz, Kyowa Kirin, Celgene, Trillium, Esai, Soligenix, and Elorac; received research grant from Celgene.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}